Skip to Content

Eurofins Scientific SE ERFSF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Eurofins, headquartered in Luxembourg, has three main business lines: food and environment testing, services to pharmaceutical and biotechnology companies, and clinical diagnostics, with the three segments contributing about 42%, 33%, and 20% of revenue, respectively. Through its subsidiaries, Eurofins provides various analytical testing and laboratory services on a global scale, and the company offers testing options for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products. The company also has a growing clinical diagnostics unit, with specialties in infectious diseases, prenatal screening, and organ transfer. Eurofins operates over 800 laboratories in 50 countries.

Contact
23 Val Fleuri
Luxembourg, L-1526, France
T +352 26185320
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Dec 31, 2011
Fiscal Year End Dec 31, 2021
Stock Type
Employees 51,516